Multi-party game trading rules Guangdong "Pharmaceutical Exchange" postponed to start

Guangdong Pharmaceutical exchange (hereinafter referred to as Guangdong Pharmaceutical exchange), originally planned to operate on July 1, was stranded due to the draft of trading rules On August 12, relevant personnel from Guangdong Provincial Department of health and Guangdong Provincial Leading Group Office of centralized drug procurement confirmed to the reporter of daily economic news that the specific operation time has not been determined temporarily because the trading rules have not been formally finalized At the end of May this year, the new regulations on drug trade in Guangdong Province were open to solicit opinions The biggest highlight was to create a third-party drug electronic trading platform, drug exchange, to realize the whole online process of bidding, trading, payment, financing and supervision The government hopes to use the drug exchange to reduce the price of controversial drugs, and insiders have high hopes Liao Xinbo, deputy director of the Department of health of Guangdong Province, once said that one of the reasons for Guangdong to explore the establishment of drug exchange was to cut off the grey interest chain of medicine However, as soon as the draft was published, many enterprises opposed it A senior person of a large pharmaceutical distribution enterprise told reporters that the delay in the rules is mainly due to the multi-party still in the game If the final Guangdong plan adheres to the "only low price winning" method, a large number of small and medium-sized enterprises will lose the market A person close to the organizer of Guangdong Pharmaceutical exchange said that the "final draft" after being questioned is still in the process of submission for review, and the "final draft after concession" may be close to the Chongqing version The rules are still in the final game In January this year, Guangdong began to lay out a new way to reduce government intervention and strengthen the role of the market At the end of May, the leading group of drug centralized purchase in Guangdong Province released the notice on Soliciting Opinions on the revision of relevant rules of drug trade in Guangdong Province (Draft for comments), formally soliciting opinions on the draft of drug exchange The reporter noted that Guangdong Pharmaceutical exchange was a teacher from Chongqing, but it also made a deep-seated reform on the basis of Chongqing version According to the above-mentioned senior personage, unlike Chongqing pharmaceutical exchange, Guangdong Pharmaceutical exchange only allows winning the bid at the lowest price, which means that there are multiple manufacturers in China with fierce competition in varieties, and those who do not win the bid will be eliminated As soon as the draft was published, a number of pharmaceutical companies expressed "great opinions", and the share prices of many listed pharmaceutical companies fell one after another Soon, China Pharmaceutical Enterprise Management Association, China Association of traditional Chinese medicine, China Association for the promotion of scientific research and development of pharmaceutical industry, China over the counter Pharmaceutical Association, China modern pharmaceutical logistics working committee and other industry associations jointly proposed the modification opinions and submitted them to the relevant government departments In the view of the insiders, the main reason why the draft is questioned is the policy tendency of "only winning the bid at low price", which will cause a heavy blow to the pharmaceutical industry A manager of a large pharmaceutical enterprise in Jiangsu once told the reporter of "daily economic news" that generally speaking, the drug bidding adopts the scoring system In terms of the scale of the enterprise, whether to give the top 50 points or the top 100 points is determined by the bidding department In addition, if some enterprises want to get the bidding policy "customized" for their products, it also depends on the bidding department Winning the bid for drugs has a great relationship with the interests of enterprises Many enterprises prefer to deliberately lower prices or collude with those in power to disrupt the market Despite the controversy, the preparations for the establishment of Guangdong Pharmaceutical exchange are still proceeding in an orderly manner On June 21, relevant leaders of Guangdong Province officially awarded the license to Guangdong drug trade center and its superior group, Guangdong property rights trading group, at the second China (Guangzhou) financial trade fair, Southern Daily reported Under the leadership of Guangdong Provincial People's government and Guangdong Provincial Leading Group Office of pharmaceutical procurement, Guangdong provincial drug exchange is a quasi public welfare wholly-owned state-owned enterprise that has been selected strictly through two rounds of three months by the government According to the daily economic news, Guangdong drug trade center is a subordinate enterprise of the people's Government of Guangdong Province and is now managed by the Department of health of Guangdong Province Currently, the drug exchange is in the process of preparation, and the operation time is unclear Relevant personnel of Guangdong Provincial Leading Group Office for centralized drug procurement said that Guangdong drug exchange and drug procurement group are two independent departments, they are not clear about each other's situation and have not received the operation notice at present It is difficult to avoid a complete supply chain of drug circulation, involving multiple interests, including production enterprises, circulation enterprises, hospitals, patients, exchanges A number of industry experts said that the "only low-cost winning" will also lead to drug price reduction From Chongqing's experience, drug price reduction is inevitable According to the public data, after the implementation of Chongqing drug exchange, through price negotiation in Fuling District of Chongqing, the transaction price of drug product regulation dropped by 52.7% compared with the online price of Chongqing drug exchange Through online transaction and price negotiation, the transaction price of basic drug regulation decreased by 27.8% compared with the centralized purchase price of Chongqing in 2010 A person who once participated in the drug bidding in Chongqing admitted that although many real estate governments have implemented sunshine bidding in recent years, the problem of drug corruption has not been solved Compared with the original drug procurement bidding mode, the probability of corruption in drug exchange is relatively small The above-mentioned senior figures pointed out that from the draft of Guangdong drug exchange, exclusive varieties, original research drugs, independent pricing and high-quality and good price varieties are less affected by the price reduction "Take the original research drug for example, many domestic generic drugs competed together Even if the cost of 80 yuan is 20 yuan, the patient will only pay 20 yuan But if the winning bidder is 60 yuan of the original research drug, the patient's medical cost will be 40 yuan more For doctors and hospitals, kickbacks and drugs plus Chengdu will make them prefer high priced drugs " The person further said that the original Chongqing model and the drug bidding model all over the country did not completely solve the problem of high drug prices.